The Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins is pleased to announce the availability of funding for a limited number of innovative developmental research projects (pilot studies) focused on pancreatic adenocarcinoma. This program supports promising new projects with strong translational potential that currently lack sufficient preliminary data to secure independent NIH funding. High-priority proposals should introduce novel research directions, explore bold or unconventional ideas, test important new hypotheses, or assess the feasibility of new experimental approaches. Applications are due by 5:00 p.m. on Friday, August 30, 2025.